GE HealthCare Technologies Inc. (NASDAQ:GEHC) Stock Position Lifted by V Square Quantitative Management LLC

V Square Quantitative Management LLC lifted its stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 51.5% during the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 4,558 shares of the company’s stock after purchasing an additional 1,550 shares during the quarter. V Square Quantitative Management LLC’s holdings in GE HealthCare Technologies were worth $414,000 at the end of the most recent reporting period.

Other institutional investors have also bought and sold shares of the company. Capital Research Global Investors lifted its stake in shares of GE HealthCare Technologies by 2.8% in the 4th quarter. Capital Research Global Investors now owns 51,344,719 shares of the company’s stock worth $3,969,975,000 after acquiring an additional 1,401,566 shares during the period. Vanguard Group Inc. boosted its stake in GE HealthCare Technologies by 14.7% during the 3rd quarter. Vanguard Group Inc. now owns 44,531,402 shares of the company’s stock valued at $3,029,917,000 after purchasing an additional 5,693,244 shares in the last quarter. Hotchkis & Wiley Capital Management LLC increased its position in shares of GE HealthCare Technologies by 9.4% during the 4th quarter. Hotchkis & Wiley Capital Management LLC now owns 5,511,973 shares of the company’s stock valued at $426,186,000 after purchasing an additional 471,910 shares during the period. Invesco Ltd. raised its stake in shares of GE HealthCare Technologies by 21.4% in the 3rd quarter. Invesco Ltd. now owns 5,048,262 shares of the company’s stock worth $343,484,000 after buying an additional 889,297 shares in the last quarter. Finally, Northern Trust Corp lifted its holdings in shares of GE HealthCare Technologies by 8.9% in the third quarter. Northern Trust Corp now owns 4,205,506 shares of the company’s stock valued at $286,143,000 after buying an additional 342,040 shares during the period. Institutional investors and hedge funds own 82.06% of the company’s stock.

Insider Buying and Selling at GE HealthCare Technologies

In other news, insider Frank R. Jimenez acquired 1,315 shares of GE HealthCare Technologies stock in a transaction that occurred on Wednesday, May 1st. The stock was purchased at an average price of $76.52 per share, with a total value of $100,623.80. Following the completion of the transaction, the insider now owns 75,796 shares in the company, valued at $5,799,909.92. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. In other news, CEO Jan Makela sold 66,955 shares of the stock in a transaction on Wednesday, May 15th. The shares were sold at an average price of $81.54, for a total transaction of $5,459,510.70. Following the transaction, the chief executive officer now owns 63,348 shares in the company, valued at approximately $5,165,395.92. The sale was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, insider Frank R. Jimenez purchased 1,315 shares of the business’s stock in a transaction dated Wednesday, May 1st. The shares were acquired at an average price of $76.52 per share, for a total transaction of $100,623.80. Following the acquisition, the insider now directly owns 75,796 shares in the company, valued at approximately $5,799,909.92. The disclosure for this purchase can be found here. Company insiders own 0.27% of the company’s stock.

GE HealthCare Technologies Stock Down 1.6 %

Shares of GEHC traded down $1.32 during mid-day trading on Wednesday, reaching $80.62. The company’s stock had a trading volume of 1,632,934 shares, compared to its average volume of 3,256,683. The company has a market cap of $36.80 billion, a price-to-earnings ratio of 23.57, a price-to-earnings-growth ratio of 2.94 and a beta of 1.26. The business has a fifty day moving average of $85.49 and a 200 day moving average of $80.42. The company has a quick ratio of 0.83, a current ratio of 1.06 and a debt-to-equity ratio of 1.11. GE HealthCare Technologies Inc. has a 1 year low of $62.35 and a 1 year high of $94.50.

GE HealthCare Technologies (NASDAQ:GEHC) last announced its quarterly earnings data on Tuesday, April 30th. The company reported $0.90 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.90. GE HealthCare Technologies had a return on equity of 25.32% and a net margin of 8.05%. The firm had revenue of $4.65 billion during the quarter, compared to the consensus estimate of $4.80 billion. During the same period in the prior year, the business earned $0.85 EPS. The business’s revenue for the quarter was down 1.2% on a year-over-year basis. As a group, analysts forecast that GE HealthCare Technologies Inc. will post 4.27 earnings per share for the current fiscal year.

GE HealthCare Technologies Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, May 15th. Investors of record on Friday, April 19th were given a dividend of $0.03 per share. This represents a $0.12 dividend on an annualized basis and a yield of 0.15%. The ex-dividend date was Thursday, April 18th. GE HealthCare Technologies’s payout ratio is presently 3.51%.

Wall Street Analysts Forecast Growth

GEHC has been the topic of several research reports. Morgan Stanley boosted their price target on shares of GE HealthCare Technologies from $74.00 to $86.00 and gave the stock an “equal weight” rating in a research report on Monday, February 12th. HSBC initiated coverage on shares of GE HealthCare Technologies in a research note on Thursday, February 15th. They set a “buy” rating and a $100.00 target price for the company. Mizuho decreased their price target on shares of GE HealthCare Technologies from $110.00 to $105.00 and set a “buy” rating on the stock in a research report on Wednesday, May 1st. Evercore ISI upped their price target on GE HealthCare Technologies from $93.00 to $100.00 and gave the company an “outperform” rating in a report on Thursday, April 4th. Finally, Argus raised their price objective on GE HealthCare Technologies from $80.00 to $110.00 and gave the stock a “buy” rating in a research note on Monday, April 1st. Four investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company. According to data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus price target of $94.80.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.